Carl Zeiss Meditec (OTCMKTS:CZMWY) Stock Rating Lowered by Zacks Research

Carl Zeiss Meditec (OTCMKTS:CZMWY) was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Monday,Zacks.com reports.

Separately, Sanford C. Bernstein cut shares of Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th. One analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Carl Zeiss Meditec Price Performance

Shares of CZMWY opened at $30.72 on Monday. Carl Zeiss Meditec has a twelve month low of $26.65 and a twelve month high of $72.57. The firm has a fifty day simple moving average of $29.83 and a two-hundred day simple moving average of $37.46.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.